CompoAtlas

MULTIVITAMINES SÉNIOR

Food supplement declared in France, declaration No 2024-5-1371, decision dated 27 May 2024

MULTIVITAMINES SÉNIOR (CARÉLINK) is a food supplement declared in France. Status: declared in France, may be marketed. 1 rule of use applies to its ingredients (limits and warnings).

Brand
CARÉLINK
Food business operator placing the product on the market
H2V LABORATOIRE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 à 2 compriméS
Directions for use
1 à 2 comprimés par jour, avec un grand verre d’eau, en cure de 30 jours plusieurs fois par an.
Not recommended (according to the manufacturer)
Adolescents (under 18), Taking anticoagulants, Taking antidepressants, Prolonged use
Objectives stated by the manufacturer (these are not authorised claims)
Antioxidant, Arteries and cholesterol, Joints, Hair and nails, Blood and lymphatic circulation, Growth and development, Memory, Eye / Vision, Bones

Declaration 142083, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Bacopa monnieri (L.) Wettst.Parties aériennesExtrait sec hydroalcoolique250 mg
Ginkgo biloba L.FeuilleExtrait sec hydroalcoolique50 mg

Other active ingredients

NamePer day
Lutéinenot declared
Zéaxanthinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
D-biotineBiotine (vitamine B8)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Béta-carotèneBêta-carotènepas de limite (données insuffisantes)no fixed dose
Gluconate de cuivreCuivre5,000 µg2,000 µg
Gluconate ferreuxFer40 mg (safe level)14 mg
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
Oxyde de magnésiumMagnésium250 mg300 mg
Gluconate de manganèseManganèse8 mg (safe level)3.5 mg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Levure enrichie en séléniumSélénium255 µg50 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulled by the French Council of State in 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Gluconate de zincZinc25 mg15 mg

Additives

E570, E460, Hydroxypropyl Méthyl Cellulose, E470b

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Contient du bêta-carotène. Déconseillé aux fumeurs et aux personnes souffrant de maladies ayant pour conséquence une accumulation anormale de fer (hémochromatose, polyglobulie...). Déconseillé aux personnes sous traitements anti-dépresseur et anti-coagulant. Déconseillé en usage prolongé.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ginkgo biloba L.
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : CARÉLINK

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line